Welcome to PolyProx Therapeutics

PolyProx Therapeutics is a biotechnology company focused on the discovery and development of a new class of drugs, Polyproxin® molecules, to treat cancer and neurodegenerative diseases. Polyproxin® molecules are biopharmaceuticals that selectively target disease-causing proteins and use natural cellular pathways to degrade or remove these proteins.


About Us

Find out more about our current focus to develop Polyproxin® drug candidates for use in the treatment of cancers.


News & Events

Catch up on the latest news, developments and press releases relating to PolyProx Therapeutics.


From the global biotechnology industry, to leading academic research and pharmaceutical discovery, our team shares a vast range of knowledge and experience.